Smith & Nephew Repurchases 1.42 Million Shares in Latest Buyback Tranche as $250m Programme Passes Halfway

Smith & Nephew's $250 Million Buyback Programme: Background and Mandate

Smith & Nephew launched its USD $250 million share buyback programme on 6 May 2026, the same date as its Annual General Meeting at which shareholders granted the authority for the company to repurchase its own shares. The programme represents a commitment by the board to return a defined quantum of capital to shareholders through market purchases, a mechanism that reduces the company's share count and, all else being equal, may support Earnings Per Share over time.

Buyback programmes of this scale are a common tool among large-cap FTSE 100 companies seeking to deploy surplus cash or signal Balance Sheet confidence. The announcement states that purchases are being made in accordance with the authority granted at the AGM and in compliance with UKLR 9.6.6R, the UK Listing Rules provision that requires timely disclosure of transactions in own shares. The involvement of Merrill Lynch International as the executing broker is a standard arrangement allowing the programme to proceed within defined parameters even during closed or restricted periods.

Week-by-Week Breakdown of Shares Purchased Between 19 and 25 June 2026

Across the five trading days covered by the announcement, Smith & Nephew repurchased a total of 1,421,390 ordinary shares. The daily volumes were broadly consistent, ranging from 259,030 shares on 24 June to 310,027 shares on 22 June. The announcement sets out the lowest, highest, and average price paid for each day, allowing investors to assess how the company's Brokers navigated intraday price movements.

On 19 June 2026, the company purchased 292,656 shares at an average price of 1,132.21p, with a daily range between 1,126.00p and 1,140.50p. On 22 June, 310,027 shares were acquired at an average of 1,120.09p, the lowest daily average of the week. The 23 June session saw 300,196 shares bought at an average of 1,119.23p. On 24 June, volumes fell to 259,030 shares but the average price rose to 1,146.82p, while on 25 June, 259,481 shares were purchased at an average of 1,149.29p — the highest average price of the week. The volume-weighted average price across all transactions on the London Stock Exchange for the period was 1,132.60p (£11.3260), according to the announcement's aggregate schedule.

Execution Venue and Broker: All Trades Routed Through the London Stock Exchange

The aggregate schedule of purchases confirms that all 1,421,390 shares repurchased during the week ending 25 June 2026 were executed on the London Stock Exchange. No trades were routed through alternative venues including CBOE Europe BXE, CBOE Europe CXE, Turquoise, or Aquis Stock Exchange, each of which recorded nil volume for the period. This concentration of activity on the primary exchange is consistent with the Liquidity profile of a FTSE 100 constituent and reflects the typical execution approach for large buyback mandates.

Merrill Lynch International acted as the sole Investment firm executing these purchases on behalf of Smith & Nephew. The announcement notes that detailed information on individual trades is available via a PDF document published on the London Stock Exchange's RNS system, as required under Article 5(1)(b) of Regulation (EU) No 596/2014 as incorporated into UK domestic law through the European Union (Withdrawal) Act 2018. This granular trade-level disclosure is a standard regulatory requirement designed to ensure market transparency and prevent any suggestion of market manipulation in the context of a company purchasing its own securities.

Cumulative Programme Progress: Over $136 Million Deployed Since May

Since the programme commenced on 8 May 2026, Smith & Nephew has repurchased a cumulative total of 9,076,588 ordinary shares at a total cost of $136,865,850.21. This means the company has deployed approximately 54.7% of its $250 million buyback budget within the first seven weeks of execution, suggesting a relatively steady and methodical pace of purchases. The remaining approximately $113 million is yet to be deployed, though the company has not disclosed a specific end date or timeline for completion of the full programme.

The rate of spend implies that, if maintained at a broadly similar weekly pace, the full programme could be completed within the next two to three months, though this is an observation based on the disclosed run-rate and not a projection confirmed by the company. Smith & Nephew has not provided forward guidance on the cadence of future tranches in this announcement. The company did not disclose this figure in the announcement regarding any expected completion date.

Treasury Share Holdings and Impact on Issued Share Capital

Following the purchases disclosed in this announcement, Smith & Nephew now holds 32,697,503 of its ordinary shares in treasury. Treasury shares are shares that have been repurchased by the company and held rather than immediately cancelled; they carry no voting rights and are not entitled to dividends. The company has stated its intention to either cancel these treasury shares or retain them for the purpose of satisfying awards under employee share plans, which is a common dual-purpose approach adopted by major UK corporates.

The company's issued share capital, excluding treasury shares, now stands at 845,036,247 ordinary shares of US 20¢ each, with one voting right per share. The announcement explicitly states that this figure of 845,036,247 should be used by shareholders as the denominator when calculating whether they are required to notify a change in their interest under the FCA's Disclosure Guidance and Transparency Rules (DTR 5). Institutional investors and substantial shareholders will need to take note of this updated figure when assessing their percentage holdings and any associated notification thresholds.

Regulatory Framework Governing the Buyback Disclosures

This announcement is made in accordance with UKLR 9.6.6R, the relevant provision of the UK Listing Rules that obliges listed companies to disclose transactions in their own shares. The requirement is designed to maintain an orderly and transparent market by ensuring that the public is promptly informed whenever an issuer acquires its own securities, thus preventing information asymmetries that could disadvantage ordinary investors.

The individual trade-level disclosure, provided via the linked PDF, satisfies the requirements of Article 5(1)(b) of the Market Abuse Regulation (as retained in UK law). This dual reporting — both a summary announcement and a detailed schedule of individual transactions — reflects the layered transparency obligations applied to share buyback programmes in the UK. Compliance with these requirements is a standard expectation for any FTSE-listed company operating a buyback mandate, and the announcement confirms that Smith & Nephew is meeting these obligations in full.

What the Buyback Signals About Smith & Nephew's Capital Allocation Strategy

A buyback programme of $250 million signals that Smith & Nephew's board views the current share price as an attractive level at which to return capital to shareholders, and that the company has sufficient financial flexibility to commit to this programme alongside its operational investment requirements. For a medical technology company of Smith & Nephew's size, sustaining investment in research, development, and commercial infrastructure while simultaneously returning capital through Buybacks indicates a degree of balance sheet confidence.

It is important to note, however, that the existence of a buyback programme does not guarantee future share price performance, and the decision to repurchase shares at any given price level is an expression of management's view at that point in time, subject to ongoing review. The company has not made any statements in this announcement regarding the outlook for its underlying Business, financial performance, or future Dividend policy. Investors monitoring the buyback should consider it as one component of a broader capital allocation framework rather than a standalone indicator of business health.

Share Price Context During the Repurchase Window

The prices paid across the five days covered by this announcement — ranging from a lowest daily low of 1,105.00p on 23 June to a highest daily high of 1,159.50p on 24 June — provide a narrow window into the trading range at which Smith & Nephew shares were changing hands during the week ending 25 June 2026. The spread between the week's absolute low and absolute high of approximately 54.5p, or roughly 4.8%, suggests moderate intraday and day-to-day price variation over the period.

The immediate share price impact of the individual weekly buyback disclosure was not clear from available public information. Buyback announcements of this routine, disclosure-driven nature — as distinct from an initial announcement of a programme — typically have a limited short-term market impact, as the existence and parameters of the programme are already known to the market. However, the cumulative evidence that the company is actively and consistently deploying capital at these price levels may be noted by analysts tracking the stock's technical and fundamental profile.

Denominator Update and Implications for Significant Shareholders

With the updated denominator now standing at 845,036,247 ordinary shares (excluding treasury shares), any Shareholder or potential investor with a position approaching the 3%, 5%, 10%, or other statutory notification thresholds under the FCA's DTR 5 will need to recalculate their percentage interest using this revised figure. As Smith & Nephew continues to repurchase shares, the denominator will continue to reduce incrementally each week, meaning that passive holders whose share counts have not changed may find their percentage ownership gradually creeping upward.

This is a technical but practically important consideration for institutional investors holding large positions in the company. For example, an investor holding a fixed number of shares will see their proportional stake rise as the denominator shrinks through buybacks, potentially triggering a mandatory notification obligation even if they have taken no active trading decision. Compliance teams at major asset managers and Hedge Funds with exposure to SN. shares should monitor denominator updates in tandem with their own position management.

Outlook for Remaining Buyback Tranches and Investor Considerations

With approximately $113 million of the $250 million programme still to be deployed as of 25 June 2026, investors can expect further weekly disclosure announcements from Smith & Nephew in the weeks ahead. Each announcement will update the market on the number of shares purchased, the price range, the cumulative spend, and the revised treasury share count and denominator. These disclosures will continue to be made in accordance with UKLR 9.6.6R and will be published via the Regulatory News Service.

Investors monitoring the progress of the buyback may be watching for any variation in weekly purchase volumes or price ranges as a potential indicator of changes in broking strategy or market conditions. Any decision by the company to pause, accelerate, or terminate the programme ahead of its natural conclusion would itself require a regulatory announcement. As of the date of this disclosure, however, the company has given no indication of any intention to deviate from the programme as originally constituted, and the pace of execution to date suggests a steady, systematic approach to completing the full $250 million mandate.